Emergent BioSolutions(EBS) - 2025 Q1 - Quarterly Results

| ( $in millions, except per share amounts) | | Q1 2025 | | Q1 2024 | % Change | | --- | --- | --- | --- | --- | --- | | Total Revenues |$ | 222.2 | $| 300.4 | (26)% | | Net Income |$ | 68.0 | $| 9.0 | 656 % | | Net Income per Diluted Share |$ | 1.19 | $| 0.17 | 600 % | | (2) Adjusted Net Income |$ | 40.7 | $| 31.1 | 31 % | | (2) Adjusted Net Income per Diluted Share |$ | 0.71 | $| 0.59 | 20 % | | (2) Adjusted EBITDA |$ | 77.6 | $ | 66.9 | 16 % | | (2) Adjusted EBITDA Margin | | 35 % | | 22 % | | ...